adamantane has been researched along with Allodynia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kolik, LG; Konstantinopolsky, MA | 1 |
Barna, I; Király, K; Kozsurek, M; Lambeir, AM; Luyten, W; Puskár, Z; Rónai, AZ; Szalai, J; Szentirmay, A | 1 |
Bihel, F; Bockel, F; Bourguignon, JJ; Elhabazi, K; Maldonado, R; Meziane, H; Mollereau, C; Moulédous, L; Petit-demoulière, B; Schmitt, M; Simonin, F; Trigo, JM; Zajac, JM | 1 |
Bourguignon, JJ; Jhamandas, JH; Kieffer, BL; Laboureyras, E; Laulin, JP; Laurent, P; MacTavish, D; Matifas, A; Mollereau, C; Parmentier, M; Schmitt, M; Simonin, F; Simonnet, G | 1 |
4 other study(ies) available for adamantane and Allodynia
Article | Year |
---|---|
Comparative Assessment of the Effectiveness of Noncompetitive NMDA Receptor Antagonists Amantadine and Hemantane in Morphine Withdrawal Syndrome Model.
Topics: Adamantane; Amantadine; Animals; Gene Expression; Hyperalgesia; Injections, Intraperitoneal; Male; Morphine; Morphine Dependence; Motor Activity; Narcotic Antagonists; Rats; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome; Weight Loss | 2019 |
The dipeptidyl peptidase IV (CD26, EC 3.4.14.5) inhibitor vildagliptin is a potent antihyperalgesic in rats by promoting endomorphin-2 generation in the spinal cord.
Topics: Adamantane; Animals; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Hyperalgesia; Injections, Spinal; Injections, Subcutaneous; Male; Nitriles; Oligopeptides; Pyrrolidines; Rats; Rats, Wistar; Reproducibility of Results; Spinal Cord; Time Factors; Vildagliptin | 2011 |
Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments.
Topics: Adamantane; Analgesics, Opioid; Animals; Behavior, Animal; Conditioning, Classical; Dipeptides; Drug Tolerance; Fentanyl; Hot Temperature; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Morphine; Motor Activity; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Pain; Receptors, Neuropeptide; Substance Withdrawal Syndrome | 2012 |
RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia.
Topics: Adamantane; Amides; Analgesics, Opioid; Animals; Blood Pressure; Chlorocebus aethiops; COS Cells; Dipeptides; Drug Tolerance; Heart Rate; Heroin; Humans; Hyperalgesia; Ligands; Molecular Structure; Rats; Receptors, Neuropeptide | 2006 |